1
|
Gnerlich JL, Deshpande AD, Jeffe DB,
Seelam S, Kimbuende E and Margenthaler JA: Poorer survival outcomes
for male breast cancer compared with female breast cancer may be
attributable to in-stage migration. Ann Surg Oncol. 18:1837–1844.
2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Bertolini F: Adipose tissue and breast
cancer progression: A link between metabolism and cancer. Breast.
22(Suppl 2): S48–S49. 2013. View Article : Google Scholar : PubMed/NCBI
|
3
|
Song J, Su H, Zhou YY and Guo LL:
Prognostic value of matrix metalloproteinase 9 expression in breast
cancer patients: A meta-analysis. Asian Pac J Cancer Prev.
14:1615–1621. 2013. View Article : Google Scholar : PubMed/NCBI
|
4
|
Yang S and Han H: Effect of
cycloxygenase-2 silencing on the malignant biological behavior of
MCF-7 breast cancer cells. Oncol Lett. 8:1628–1634. 2014.PubMed/NCBI
|
5
|
Jin ML, Park SY, Kim YH, Park G and Lee
SJ: Halofuginone induces the apoptosis of breast cancer cells and
inhibits migration via downregulation of matrix
metalloproteinase-9. Int J Oncol. 44:309–318. 2014.
|
6
|
Liao YF, Rao YK and Tzeng YM: Aqueous
extract of Anisomeles indica and its purified compound exerts
anti-metastatic activity through inhibition of NF-κB/AP-1-dependent
MMP-9 activation in human breast cancer MCF-7 cells. Food Chem
Toxicol. 50:2930–2936. 2012. View Article : Google Scholar : PubMed/NCBI
|
7
|
Kim YS, Sull JW and Sung HJ: Suppressing
effect of resveratrol on the migration and invasion of human
metastatic lung and cervical cancer cells. Mol Biol Rep.
39:8709–8716. 2012. View Article : Google Scholar : PubMed/NCBI
|
8
|
Chakraborty A, Gupta N, Ghosh K and Roy P:
In vitro evaluation of the cytotoxic, anti-proliferative and
anti-oxidant properties of pterostilbene isolated from Pterocarpus
marsupium. Toxicol In Vitro. 24:1215–1228. 2010. View Article : Google Scholar : PubMed/NCBI
|
9
|
Harikumar KB, Kunnumakkara AB, Sethi G,
Diagaradjane P, Anand P, Pandey MK, Gelovani J, Krishnan S, Guha S
and Aggarwal BB: Resveratrol, a multitargeted agent, can enhance
antitumor activity of gemcitabine in vitro and in orthotopic mouse
model of human pancreatic cancer. Int J Cancer. 127:257–268.
2010.
|
10
|
Amri A, Chaumeil JC, Sfar S and Charrueau
C: Administration of resveratrol: What formulation solutions to
bioavailability limitations? J Control Release. 158:182–193. 2012.
View Article : Google Scholar
|
11
|
Pangeni R, Sahni JK, Ali J, Sharma S and
Baboota S: Resveratrol: Review on therapeutic potential and recent
advances in drug delivery. Expert Opin Drug Deliv. 11:1285–1298.
2014. View Article : Google Scholar : PubMed/NCBI
|
12
|
Nicol JR, Dixon D and Coulter JA: Gold
nanoparticle surface functionalization: A necessary requirement in
the development of novel nanotherapeutics. Nanomedicine.
10:1315–1326. 2015. View Article : Google Scholar : PubMed/NCBI
|
13
|
Park H, Tsutsumi H and Mihara H: Cell
penetration and cell-selective drug delivery using α-helix peptides
conjugated with gold nanoparticles. Biomaterials. 34:4872–4879.
2013. View Article : Google Scholar : PubMed/NCBI
|
14
|
Karuppaiya P, Satheeshkumar E, Chao WT,
Kao LY, Chen EC and Tsay HS: Anti-metastatic activity of
biologically synthesized gold nanoparticles on human fibrosarcoma
cell line HT-1080. Colloids Surf B Biointerfaces. 110:163–170.
2013. View Article : Google Scholar : PubMed/NCBI
|
15
|
Suganya KS, Govindaraju K, Kumar VG, Dhas
TS, Karthick V, Singaravelu G and Elanchezhiyan M: Blue green alga
mediated synthesis of gold nanoparticles and its antibacterial
efficacy against Gram positive organisms. Mater Sci Eng C.
47:351–356. 2015. View Article : Google Scholar
|
16
|
Sanna V, Pala N, Dessì G, Manconi P,
Mariani A, Dedola S, Rassu M, Crosio C, Iaccarino C and Sechi M:
Single-step green synthesis and characterization of gold-conjugated
polyphenol nanoparticles with antioxidant and biological
activities. Int J Nanomedicine. 9:4935–4951. 2014.PubMed/NCBI
|
17
|
Kondath S, Srinivas Raghavan B,
Anantanarayanan R and Rajaram R: Synthesis and characterisation of
morin reduced gold nanoparticles and its cytotoxicity in MCF-7
cells. Chem Biol Interact. 224C:78–88. 2014. View Article : Google Scholar : PubMed/NCBI
|
18
|
Barathmanikanth S, Kalishwaralal K, Sriram
M, Pandian SR, Youn HS, Eom S and Gurunathan S: Anti-oxidant effect
of gold nanoparticles restrains hyperglycemic conditions in
diabetic mice. J Nanobiotechnology. 8:162010. View Article : Google Scholar : PubMed/NCBI
|
19
|
Khan HA, Abdelhalim MA, Alhomida AS and Al
Ayed MS: Transient increase in IL-1β, IL-6 and TNF-α gene
expression in rat liver exposed to gold nanoparticles. Genet Mol
Res. 12:5851–5857. 2013. View Article : Google Scholar : PubMed/NCBI
|
20
|
Kumar CG, Poornachandra Y and Mamidyala
SK: Green synthesis of bacterial gold nanoparticles conjugated to
resveratrol as delivery vehicles. Colloids Surf B Biointerfaces.
123:311–317. 2014. View Article : Google Scholar : PubMed/NCBI
|
21
|
Chao CY, Lii CK, Hsu YT, Lu CY, Liu KL, Li
CC and Chen HW: Induction of heme oxygenase-1 and inhibition of
TPA-induced matrix metalloproteinase-9 expression by
andrographolide in MCF-7 human breast cancer cells. Carcinogenesis.
34:1843–1851. 2013. View Article : Google Scholar : PubMed/NCBI
|
22
|
Lee CW, Yen FL, Huang HW, Wu TH, Ko HH,
Tzeng WS and Lin CC: Resveratrol nanoparticle system improves
dissolution properties and enhances the hepatoprotective effect of
resveratrol through antioxidant and anti-inflammatory pathways. J
Agric Food Chem. 60:4662–4671. 2012. View Article : Google Scholar : PubMed/NCBI
|
23
|
Li J, Wang X, Wang C, Chen B, Dai Y, Zhang
R, Song M, Lv G and Fu D: The enhancement effect of gold
nanoparticles in drug delivery and as biomarkers of drug-resistant
cancer cells. ChemMedChem. 2:374–378. 2007. View Article : Google Scholar : PubMed/NCBI
|
24
|
Correard F, Maximova K, Estève MA, Villard
C, Roy M, Al-Kattan A, Sentis M, Gingras M, Kabashin AV and Braguer
D: Gold nanoparticles prepared by laser ablation in aqueous
biocompatible solutions: Assessment of safety and biological
identity for nanomedicine applications. Int J Nanomedicine.
9:5415–5430. 2014.PubMed/NCBI
|
25
|
Lee WY, Chen YC, Shih CM, Lin CM, Cheng
CH, Chen KC and Lin CW: The induction of heme oxygenase-1
suppresses heat shock protein 90 and the proliferation of human
breast cancer cells through its byproduct carbon monoxide. Toxicol
Appl Pharmacol. 274:55–62. 2014. View Article : Google Scholar
|
26
|
Lin CW, Shen SC, Hou WC, Yang LY and Chen
YC: Heme oxygenase-1 inhibits breast cancer invasion via
suppressing the expression of matrix metalloproteinase-9. Mol
Cancer Ther. 7:1195–1206. 2008. View Article : Google Scholar : PubMed/NCBI
|